Company intelligence / Profile preview
Biocure Med
Vancouver, British Columbia, Canada
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Biocure Technology is a biopharmaceutical company focused on the development and commercialization of biosimilars and advanced cell therapies. Headquartered in Vancouver with its primary R&D operations in South Korea through its subsidiary BiocurePharm, the company specializes in high-demand biologics such as Filgrastim and Ranibizumab. A significant portion of its pipeline is dedicated to CAR-T cell therapy, specifically targeting CD19 for the treatment of various blood cancers. Biocure aims to provide cost-effective alternatives to expensive brand-name biologics while advancing next-generation immunotherapy solutions. The company is currently advancing its lead CAR-T candidate through clinical trials in South Korea.
- Therapeutic areas
- OncologyNeurologyOphthalmologyHematology
- Modalities
- CAR-T cell therapyRecombinant proteinMonoclonal antibody fragmentCytokineCell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Pharos Vaccine
Beyond the preview
Go deeper on Biocure Med.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biocure Med.